2024 : 9 : 8
Shahram Ghasemi

Shahram Ghasemi

Academic rank: Associate Professor
ORCID:
Education: PhD.
ScopusId:
HIndex:
Faculty: Faculty of Chemistry
Address: Dept. of Applied Chemistry, Faculty of Chemistry, University of Mazandaran
Phone: 01135302388

Research

Title
Sub-acute administration of metal-organic Framework-5 induces behavioral impairments and augments the levels of oxidative stress and inflammation in the brain of rats
Type
JournalPaper
Keywords
Metal-organic frameworkMOF-5NeurotoxicityOxidative stressInflammatory mediators
Year
2024
Journal Food and Chemical Toxicology
DOI
Researchers Fatemeh Naghdi Babaei ، Moein Shirzad ، Maryam Ghasemi-Kasman ، Sara Ghadir ، Hasaniani Nima ، Shahram Ghasemi ، Danial Amiri Manjili

Abstract

Metal-organic frameworks (MOFs) are known as potential pharmaceutical carriers because of their structure. Here, we evaluated the sub-acute administrations of MOF-5 on behavioral parameters, oxidative stress, and inflammation levels in rats. Thirty-two male Wistar rats received four injections of saline or MOF-5 at different doses which were 1, 10, and 50 mg/kg via caudal vein. Y-Maze and Morris-Water Maze (MWM) tests were used to explore working memory and spatial learning and memory, respectively. The antioxidant capacity and oxidative stress level of brain samples were assessed by ferric reducing antioxidant power (FRAP) and thiobarbituric acid-reacting substance (TBARS) assay, respectively. The expression levels of GFAP, IL-1β, and TNF-α were also measured by quantitative real-time reverse-transcription PCR (qRT-PCR). Sub-acute administration of MOF-5 reduced the spatial learning and memory as well as working memory, dose-dependently. The levels of FRAP were significantly reduced in rats treated with MOF-5 at higher doses. The Malondialdehyde (MDA) levels increased at the dose of 50 mg/kg. Additionally, the expression levels of IL-1β and TNF-α were significantly elevated in the rats’ brains that were treated with MOF-5. Our findings indicate that sub-acute administration of MOF-5 induces cognitive impairment dose-dependently which might be partly mediated by increasing oxidative stress and inflammation.